company background image
CYRX logo

Cryoport NasdaqCM:CYRX Stock Report

Last Price

US$7.50

Market Cap

US$367.8m

7D

5.8%

1Y

-48.3%

Updated

04 Dec, 2024

Data

Company Financials +

CYRX Stock Overview

Provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. More details

CYRX fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Cryoport, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Cryoport
Historical stock prices
Current Share PriceUS$7.50
52 Week HighUS$20.11
52 Week LowUS$5.32
Beta1.62
11 Month Change-2.22%
3 Month Change-8.65%
1 Year Change-48.33%
33 Year Change-89.25%
5 Year Change-47.70%
Change since IPO-93.24%

Recent News & Updates

Investors Continue Waiting On Sidelines For Cryoport, Inc. (NASDAQ:CYRX)

Dec 03
Investors Continue Waiting On Sidelines For Cryoport, Inc. (NASDAQ:CYRX)

Is Cryoport (NASDAQ:CYRX) A Risky Investment?

Nov 06
Is Cryoport (NASDAQ:CYRX) A Risky Investment?

Recent updates

Investors Continue Waiting On Sidelines For Cryoport, Inc. (NASDAQ:CYRX)

Dec 03
Investors Continue Waiting On Sidelines For Cryoport, Inc. (NASDAQ:CYRX)

Is Cryoport (NASDAQ:CYRX) A Risky Investment?

Nov 06
Is Cryoport (NASDAQ:CYRX) A Risky Investment?

The Market Lifts Cryoport, Inc. (NASDAQ:CYRX) Shares 36% But It Can Do More

Aug 09
The Market Lifts Cryoport, Inc. (NASDAQ:CYRX) Shares 36% But It Can Do More

Health Check: How Prudently Does Cryoport (NASDAQ:CYRX) Use Debt?

Jul 22
Health Check: How Prudently Does Cryoport (NASDAQ:CYRX) Use Debt?

Slammed 28% Cryoport, Inc. (NASDAQ:CYRX) Screens Well Here But There Might Be A Catch

Jun 25
Slammed 28% Cryoport, Inc. (NASDAQ:CYRX) Screens Well Here But There Might Be A Catch

Potential Upside For Cryoport, Inc. (NASDAQ:CYRX) Not Without Risk

Apr 15
Potential Upside For Cryoport, Inc. (NASDAQ:CYRX) Not Without Risk

Cryoport, Inc. (NASDAQ:CYRX) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?

Mar 15
Cryoport, Inc. (NASDAQ:CYRX) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?

Cryoport Tanks On Chilling Results And Bad Decisions

Mar 14

Is Cryoport (NASDAQ:CYRX) Using Debt In A Risky Way?

Mar 10
Is Cryoport (NASDAQ:CYRX) Using Debt In A Risky Way?

Fewer Investors Than Expected Jumping On Cryoport, Inc. (NASDAQ:CYRX)

Jan 15
Fewer Investors Than Expected Jumping On Cryoport, Inc. (NASDAQ:CYRX)

Health Check: How Prudently Does Cryoport (NASDAQ:CYRX) Use Debt?

Oct 06
Health Check: How Prudently Does Cryoport (NASDAQ:CYRX) Use Debt?

Downgrade: Here's How Analysts See Cryoport, Inc. (NASDAQ:CYRX) Performing In The Near Term

Jul 23
Downgrade: Here's How Analysts See Cryoport, Inc. (NASDAQ:CYRX) Performing In The Near Term

Cryoport, Inc.'s (NASDAQ:CYRX) Subdued P/S Might Signal An Opportunity

Jul 12
Cryoport, Inc.'s (NASDAQ:CYRX) Subdued P/S Might Signal An Opportunity

Is Cryoport (NASDAQ:CYRX) A Risky Investment?

Jun 13
Is Cryoport (NASDAQ:CYRX) A Risky Investment?

Cryoport, Inc.'s (NASDAQ:CYRX) Intrinsic Value Is Potentially 96% Above Its Share Price

Mar 06
Cryoport, Inc.'s (NASDAQ:CYRX) Intrinsic Value Is Potentially 96% Above Its Share Price

Cryoport, Inc. (NASDAQ:CYRX) Analysts Just Cut Their EPS Forecasts Substantially

Nov 07
Cryoport, Inc. (NASDAQ:CYRX) Analysts Just Cut Their EPS Forecasts Substantially

Is Cryoport (NASDAQ:CYRX) Using Debt In A Risky Way?

Sep 23
Is Cryoport (NASDAQ:CYRX) Using Debt In A Risky Way?

Cryoport: A Rare Investing Opportunity

Sep 22

Cryoport enters into strategic relationship with Takeda's BioLife Plasma Services

Sep 08

Cryoport: Rapid Growth Is Great, But Shares Look Overpriced

Jul 30

Cryoport: To Resume Aggressive Growth

May 11

Cryoport: An Industry Leader Basking In Industry Tailwinds

Apr 15

Cryoport: Risky Investment With Upside Potential

Apr 01

Cryoport: More Growth Going Into New Year 2022

Dec 29

Shareholder Returns

CYRXUS Life SciencesUS Market
7D5.8%1.9%0.4%
1Y-48.3%5.5%32.3%

Return vs Industry: CYRX underperformed the US Life Sciences industry which returned 5.5% over the past year.

Return vs Market: CYRX underperformed the US Market which returned 32.3% over the past year.

Price Volatility

Is CYRX's price volatile compared to industry and market?
CYRX volatility
CYRX Average Weekly Movement9.2%
Life Sciences Industry Average Movement8.9%
Market Average Movement6.3%
10% most volatile stocks in US Market16.3%
10% least volatile stocks in US Market3.1%

Stable Share Price: CYRX has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: CYRX's weekly volatility (9%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19991,100Jerry Sheltonwww.cryoportinc.com

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services.

Cryoport, Inc. Fundamentals Summary

How do Cryoport's earnings and revenue compare to its market cap?
CYRX fundamental statistics
Market capUS$367.76m
Earnings (TTM)-US$166.47m
Revenue (TTM)US$226.11m

1.6x

P/S Ratio

-2.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CYRX income statement (TTM)
RevenueUS$226.11m
Cost of RevenueUS$130.50m
Gross ProfitUS$95.61m
Other ExpensesUS$262.08m
Earnings-US$166.47m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-3.37
Gross Margin42.28%
Net Profit Margin-73.62%
Debt/Equity Ratio47.6%

How did CYRX perform over the long term?

See historical performance and comparison